Surgery Partners, Inc. (NASDAQ:SGRY) Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp boosted its holdings in Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 17.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 340,776 shares of the company's stock after purchasing an additional 51,187 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.27% of Surgery Partners worth $7,214,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. KBC Group NV grew its holdings in Surgery Partners by 31.8% in the 3rd quarter. KBC Group NV now owns 2,385 shares of the company's stock valued at $77,000 after buying an additional 576 shares during the period. Point72 Asia Singapore Pte. Ltd. grew its holdings in Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock valued at $124,000 after purchasing an additional 3,379 shares during the period. MeadowBrook Investment Advisors LLC increased its position in Surgery Partners by 16.6% during the fourth quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company's stock worth $218,000 after purchasing an additional 1,460 shares during the last quarter. Empowered Funds LLC purchased a new position in Surgery Partners during the fourth quarter worth approximately $245,000. Finally, Versor Investments LP acquired a new position in shares of Surgery Partners in the 3rd quarter valued at $271,000.

Insiders Place Their Bets

In related news, insider Harrison R. Bane sold 56,315 shares of the stock in a transaction dated Friday, February 7th. The shares were sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now owns 107,037 shares in the company, valued at $2,744,428.68. This represents a 34.47 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jason Eric Evans sold 26,520 shares of Surgery Partners stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $25.65, for a total value of $680,238.00. Following the completion of the transaction, the chief executive officer now owns 560,698 shares of the company's stock, valued at approximately $14,381,903.70. The trade was a 4.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 106,622 shares of company stock valued at $2,717,860 over the last 90 days. 2.30% of the stock is owned by company insiders.

Remove Ads

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SGRY. Bank of America began coverage on Surgery Partners in a report on Monday, December 16th. They issued a "buy" rating and a $30.00 price objective on the stock. Macquarie decreased their price target on shares of Surgery Partners from $34.00 to $33.00 and set an "outperform" rating for the company in a research report on Tuesday, March 11th. JPMorgan Chase & Co. cut their price objective on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating on the stock in a research report on Tuesday, December 3rd. Finally, Royal Bank of Canada decreased their target price on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a research report on Wednesday, November 20th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Surgery Partners currently has an average rating of "Moderate Buy" and a consensus price target of $36.63.

Surgery Partners Stock Up 0.3 %

SGRY traded up $0.07 on Wednesday, reaching $24.44. The company's stock had a trading volume of 324,302 shares, compared to its average volume of 1,062,112. The stock has a market cap of $3.12 billion, a price-to-earnings ratio of -50.84, a price-to-earnings-growth ratio of 19.21 and a beta of 2.73. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The business's 50 day moving average is $23.73 and its 200 day moving average is $25.89. Surgery Partners, Inc. has a 1 year low of $19.50 and a 1 year high of $33.97.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.01. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $864.40 million for the quarter, compared to analysts' expectations of $828.09 million. As a group, research analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.